CODX Operating Cycle from 2010 to 2026

CODX Stock  USD 2.22  0.11  4.72%   
Co Diagnostics Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle will likely drop to 441.64 in 2026. During the period from 2010 to 2026, Co Diagnostics Operating Cycle regression line of annual values had r-squared of  0.76 and arithmetic mean of  5,390. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
464.88
Current Value
441.64
Quarterly Volatility
5.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 M, Interest Expense of 18 M or Selling General Administrative of 19.5 M, as well as many indicators such as Price To Sales Ratio of 6.35, Dividend Yield of 0.0 or PTB Ratio of 0.46. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
  
Build AI portfolio with CODX Stock
Check out the analysis of Co Diagnostics Correlation against competitors.
For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.
The evolution of Operating Cycle for Co Diagnostics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Co Diagnostics compares to historical norms and industry peers.

Latest Co Diagnostics' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Co Diagnostics over the last few years. It is Co Diagnostics' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

CODX Operating Cycle Regression Statistics

Arithmetic Mean5,390
Geometric Mean1,824
Coefficient Of Variation100.48
Mean Deviation5,242
Median863.16
Standard Deviation5,416
Sample Variance29.3M
Range10.8K
R-Value(0.87)
Mean Square Error7.6M
R-Squared0.76
Slope(934.11)
Total Sum of Squares469.3M

CODX Operating Cycle History

2026 441.64
2025 464.88
2024 404.25
2023 162.92
2022 411.23
2021 141.18
2020 235.31

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 464.88  441.64 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.